Mariem Salma Abdoudaim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mariem Salma Abdoudaim has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Laurent Bélec
Laboratory of Virology, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), 75015 Paris, France
2 shared publications - Ralph-Sydney Mboumba Bouassa
Institut du Savoir Montfort, Montfort Hospital, Ottawa, ON K1K 0T2, Canada
2 shared publications Mohamed Lemine Cheikh Brahim Ahmed
Unité d'Epidémiologie Moléculaire et Diversité des Microorganismes, Faculté des Sciences et Techniques de l'Université de Nouakchott Nouakchott Mauritania
1 shared publication- Mohamed Lemine Cheikh Brahim Ahmed
University of Nouakchott El-Asriya
1 shared publication - Mohamed Vall Mohamed Abdellahi
Unité d’Épidémiologie Moléculaire et Diversité des Micro-Organismes (EMDM), Université de Nouakchott, Nouakchott, Mauritania
1 shared publication Nacer Dine Mohamed Baba
Centre Hospitalier National Nouakchott Mauritania
1 shared publication
Latest Publications
- Open Access
- 17 November 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (11)
Human Papillomavirus Viral Load as Triage Biomarker for High‐Grade Cervical Lesions and Invasive Cervical Carcinoma: A Cross‐Sectional Study
Background and Aims: We herein evaluated whether intra‐tissue HPV viral load may constitute a triage biomarker to differentiate between high‐grade precancerous cervical lesions from intra cervical cancer (ICC). Methods: 50 biopsy samples prospectively obtained from women living in Mauritania suffering from high‐grade cervical intraepithelial neoplasia (CIN2/3), adenocarcinoma (ADC) or squamous cell carcinoma (SCC) were analysed for HPV genotyping and quantitation carried out using Bioperfectus Multiplex Real Time Human Papillomavirus Genotyping Real Time PCR assay. Results: HPV‐positive results were detected in 47 biopsies (12 CIN2/3 and 35 ICC, including 4 ADC and 31 SCC). The cumulative HPV viral loads of any HPV and high risk‐HPV (HR‐HPV) in ICC were significantly higher than those in CIN2/3 ( p < 0.002 for any HPV; 0.02 for HR‐HPV). The cumulative viral loads of any HPV and HR‐HPV possessed a good discriminatory ability to differentiate between CIN2/3 and ICC, with optimal cutoffs ranging from 4.38 (any HPV) to 4.85 (HR‐HPV) copies per 10,000 cells. Conclusion: Our observations show that cumulative HPV viral load in cervical tissue may constitute a relevant biomarker associated with the severity of HPV‐related cervical lesions. HPV viral load in cervical tissue could be used as a triage tool for aggressive ICC in advanced cervical lesions.
- 17 November 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (11)
Open AccessHuman Papillomavirus Viral Load as Triage Biomarker for High‐Grade Cervical Lesions and Invasive Cervical Carcinoma: A Cross‐Sectional Study
Background and Aims: We herein evaluated whether intra‐tissue HPV viral load may constitute a triage biomarker to differentiate between high‐grade precancerous cervical lesions from intra cervical cancer (ICC). Methods: 50 biopsy samples prospectively obtained from women living in Mauritania suffering from high‐grade cervical intraepithelial neoplasia (CIN2/3), adenocarcinoma (ADC) or squamous cell carcinoma (SCC) were analysed for HPV genotyping and quantitation carried out using Bioperfectus Multiplex Real Time Human Papillomavirus Genotyping Real Time PCR assay. Results: HPV‐positive results were detected in 47 biopsies (12 CIN2/3 and 35 ICC, including 4 ADC and 31 SCC). The cumulative HPV viral loads of any HPV and high risk‐HPV (HR‐HPV) in ICC were significantly higher than those in CIN2/3 ( p < 0.002 for any HPV; 0.02 for HR‐HPV). The cumulative viral loads of any HPV and HR‐HPV possessed a good discriminatory ability to differentiate between CIN2/3 and ICC, with optimal cutoffs ranging from 4.38 (any HPV) to 4.85 (HR‐HPV) copies per 10,000 cells. Conclusion: Our observations show that cumulative HPV viral load in cervical tissue may constitute a relevant biomarker associated with the severity of HPV‐related cervical lesions. HPV viral load in cervical tissue could be used as a triage tool for aggressive ICC in advanced cervical lesions.
- Open Access
- 8 September 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (17) , 1986
Human Papillomavirus Genotypes Distribution in High-Grade Cervical Lesions and Invasive Cervical Carcinoma in Women Living in Mauritania: Implications for Cervical Cancer Prevention and HPV Prophylactic Vaccination
Cervical cancer related to high-risk human papillomavirus (HR-HPV) is the second female cancer in Mauritania (Northwest Sahelian Africa). We assessed the distribution of HPV genotypes in Mauritanian women with high-grade cervical intraepithelial neoplasia (CIN2/3) or invasive cervical cancer (ICC). A prospective study was conducted in the Centre Hospitalier National, Nouakchott, Mauritania, to collect cervical biopsies among women suspected of CIN2/3 or cancer. HPV DNA detection and genotyping were carried out from formalin-fixed, paraffin-embedded biopsies using multiplex PCR (Human Papillomavirus Genotyping Real-Time PCR Kit, Bioperfectus Technologies Co., Taizhou, China). Fifty biopsies were included from women (mean age: 56.7 years) suffering from CIN2/3 (28.0%) and ICC (72.0%) which corresponded to 32 (64.0%) squamous cell carcinomas (SCC) and 4 (8.0%) adenocarcinomas (ADC). HPV DNA detection was successful in 47 (94.0%) samples. The most prevalent HR-HPV genotypes were HPV-45 (40.4%), HPV-16 (38.3%), HPV-39 and HPV-52 (23.4%), HPV-33 (17.0%), HPV-18 (14.9%), HPV-35 (4.2%), and HPV-56 (2.1%). The majority (93.6%) of HPV-positive biopsies contained at least one HPV type covered by the 9-valent Gardasil-9® vaccine, and 40.9% were infected by multiple vaccine HPV genotypes. To eradicate cervical cancer in Mauritania, prophylactic HPV vaccination must be combined with primary molecular screening of cervical HR-HPV infection.
- 8 September 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (17) , 1986
Open AccessHuman Papillomavirus Genotypes Distribution in High-Grade Cervical Lesions and Invasive Cervical Carcinoma in Women Living in Mauritania: Implications for Cervical Cancer Prevention and HPV Prophylactic Vaccination
Cervical cancer related to high-risk human papillomavirus (HR-HPV) is the second female cancer in Mauritania (Northwest Sahelian Africa). We assessed the distribution of HPV genotypes in Mauritanian women with high-grade cervical intraepithelial neoplasia (CIN2/3) or invasive cervical cancer (ICC). A prospective study was conducted in the Centre Hospitalier National, Nouakchott, Mauritania, to collect cervical biopsies among women suspected of CIN2/3 or cancer. HPV DNA detection and genotyping were carried out from formalin-fixed, paraffin-embedded biopsies using multiplex PCR (Human Papillomavirus Genotyping Real-Time PCR Kit, Bioperfectus Technologies Co., Taizhou, China). Fifty biopsies were included from women (mean age: 56.7 years) suffering from CIN2/3 (28.0%) and ICC (72.0%) which corresponded to 32 (64.0%) squamous cell carcinomas (SCC) and 4 (8.0%) adenocarcinomas (ADC). HPV DNA detection was successful in 47 (94.0%) samples. The most prevalent HR-HPV genotypes were HPV-45 (40.4%), HPV-16 (38.3%), HPV-39 and HPV-52 (23.4%), HPV-33 (17.0%), HPV-18 (14.9%), HPV-35 (4.2%), and HPV-56 (2.1%). The majority (93.6%) of HPV-positive biopsies contained at least one HPV type covered by the 9-valent Gardasil-9® vaccine, and 40.9% were infected by multiple vaccine HPV genotypes. To eradicate cervical cancer in Mauritania, prophylactic HPV vaccination must be combined with primary molecular screening of cervical HR-HPV infection.